Personalized Medicine

The landscape of cancer diagnostics is evolving with molecular and protein biomarkers indispensable for accurate diagnosis, therapy selection, monitoring treatment response, and early detection of cancer recurrence. Kalorama Information’s The World Market for Cancer Diagnostics, 2024-2029 delivers an authoritative and comprehensive analysis of the global cancer in vitro diagnostics (IVD) market, including industry-defining trends, market…

The in vitro diagnostics (IVD) market has demonstrated robust growth, driven by technological advancements and expanding opportunities. Diagnostic testing has evolved from merely diagnosing illnesses to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product…

In recent decades, genetic technologies for research and diagnostics have transformed healthcare, offering new possibilities in precision medicine and disease management. Next-generation sequencing (NGS) has revolutionized genetic disease diagnostics and oncology, providing comprehensive insights at a relatively low cost. PCR continues to evolve, remaining a central tool in molecular diagnostics. In situ hybridization techniques (ISH)…

Precision Cancer Therapeutics, 2022 examines the current landscape of precision therapies, the significant impact they are making, and the exciting developments on the horizon. Kalorama Information has monitored the cancer treatment market for over two decades and continues to provide valuable insights into the impact of new technologies. This report is essential for understanding the…

Direct to consumer laboratory testing is also known as patient-ordered laboratory testing. A variety of tests are now available for direct to consumer testing. The growing market for direct-to-consumer laboratory testing may promote awareness of health issues and genetic diseases, which will allow patients to take a more proactive role in their healthcare. With advances…

Kalorama Information’s The World Market for Cancer Diagnostics, 2021 offers an in-depth and authoritative analysis of the rapidly evolving cancer testing industry. This comprehensive report provides market sizing, opportunity assessments, and insights into industry mergers and trends, essential for stakeholders and decision-makers in the healthcare sector.

 

Market Segments:

Explore detailed market data across key…

Companion diagnostics are revolutionizing pharmaceutical development and treatment, particularly in oncology. By identifying patients with specific biomarkers or disease-specific therapeutic targets, companion diagnostics significantly improve clinical success rates and patient outcomes. They also reduce costs by pinpointing the patient population most likely to benefit from a therapy and excluding those for whom the therapy would…

Kalorama Information has closely observed the evolution of the cancer treatment market over the past two decades, evaluating the significant impact of new technologies. The Worldwide Market for Targeted Cancer Therapeutics delves into the burgeoning field of targeted therapies, highlighting current products and some of the most promising advancements on the horizon. This report covers…